Free Beta: Procurement discovery is free; verify every opportunity on SAM.gov. Source status
OtherClosing soon

6505--Glipizide Tablets

VETERANS AFFAIRS, DEPARTMENT OF › NAC PHARMACEUTICALS (36E797)

Response deadlineOct 8, 2026 3:30 PM EDT · 2 days left
View official notice on SAM.gov (opens in a new tab)
Verify before acting. Users must verify deadlines, amendments, attachments, eligibility, and submission requirements on the official SAM.gov notice. Read the Data Disclaimer.

Key decision factors

Response deadline
Oct 8, 2026 3:30 PM EDT · 2 days left
Posted
Sep 18, 2026 12:00 AM EDT
Notice type
Presolicitation
Set-aside
Not provided or not applicable
PSC
6505 — Drugs and Biologicals
Place of performance
Not specified
Current status
Closing soon

Notice details

Official status
Closing soon
Normalized group
Other
Notice ID
da7d76da852c4a48a5b272df763ba91d
Solicitation number
36E79726R0031_1

Description

Displayed as sanitized plain text from SAM.gov. Retrieved Sep 19, 2026 10:23 PM EDT.

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0031 for an unrestricted procurement for Glipizide Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere over the successful offeror/contractor's label. This product requires unit of use packaging, as identified in the Schedule of Supplies (e.g., 90, 180, and 360 count bottles). The bottles shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation #36E79726R0031 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about July 27, 2026, with a tentative closing date of August 10, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to Deborah.Fassl@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION UNIT of USE PKG. SIZE (Tablets per Bottle) TOTAL EST. ANNUAL USAGE (Bottles) 1 GLIPIZIDE 5MG TAB Y 90 60,691 2 GLIPIZIDE 5MG TAB Y 180 58,708 3a GLIPIZIDE 5MG TAB N 500 50,084 OR 3b GLIPIZIDE 5MG TAB N 1000 25,042 4 GLIPIZIDE 10MG TAB Y 90 26,156 5 GLIPIZIDE 10MG TAB Y 180 88,612 6 GLIPIZIDE 10MG TAB Y 360 18,238 7a GLIPIZIDE 10MG TAB N 500 57,870 OR 7b GLIPIZIDE 10MG TAB N 1000 28,935

Attachments

4 attachments reported by SAM.gov

Files are hosted by SAM.gov. Open the official notice to review and download them.

View attachments on SAM.gov (opens in a new tab)

Contacts

Deb Fassl
Primary — Contract Specialist
Deborah.Fassl@va.gov
Phone: 708-786-5894

Personalized relevance

Would this fit your company?

Create company profile information with a free account to see a deterministic, explainable relevance score. Matching does not determine eligibility or win probability.

Create Free Account

Pursuit risk (separate from your match score)

Document analysis pending

Some solicitation documents have not been analyzed yet. Additional restrictions may still be present.

Pursuit risk is evaluated separately from your match score above and never changes it. This is not a legal or eligibility determination — verify against the official SAM.gov notice and attachments.